Search results
Many Patients With Advanced MCC Not Receiving Immunotherapy
Medscape· 2 days agoDespite improved survival rates and guideline recommendations, many eligible patients with...
The long, frustrating wait for better sunscreens in America
NBC News via Yahoo News· 4 days agoThe FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is...
What’s keeping the U.S. from allowing better sunscreens?
OregonLive.com· 22 hours agoAt issue is not just whether people are using enough sunscreen but what ingredients are in it. The...
Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program...
FOX 5 San Diego· 1 day agoFusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today reported financial results ...
Castle Biosciences Builds Skin Cancer Assay Data, Eyes Future Expansion as Q1 Sales Jump 74 Percent
GenomeWeb News· 5 days agoDespite facing challenges in maintaining coverage by the US Centers for Medicare and Medicaid Services for its newer squamous cell carcinoma< ...
The ABCDE's of Melanoma
ABC 2 Baltimore· 5 days agoChances are you know someone, or you have had to deal with some form of skin cancer. According to the American Academy of Dermatology, one in five people in the United States will develop skin ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 13 hours agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...
WFRV 5 Green Bay· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NASDAQ: CKPT) and certain officers. The class action ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 6 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...
Benzinga· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") CKPT and certain officers. The class action, filed in ...